Biologists and computer scientists are facing significant challenges with big data. As data sets grow, they need powerful computers to handle the massive amounts of information. High-throughput genomics has led to an explosion of data, with the European Bioinformatics Institute (EBI) storing 20 petabytes of data, including 2 petabytes from genomics. This is just a fraction of the data generated by CERN, but similar challenges exist in data storage, analysis, and sharing. Data mining in biology is complex due to the heterogeneity of biological data, which comes from various experiments and includes genetic sequences, protein interactions, and medical records. Scientists must store, analyze, and share large data sets, which is not simple. A single human genome is around 140 gigabytes, and comparing genomes requires more than a personal computer and online file-sharing applications. Cloud computing is becoming increasingly important in big data biology, allowing researchers to access computing power without needing their own hardware. The EBI is developing Embassy Cloud, a cloud-computing component for ELIXIR, which offers secure data-analysis environments. Cloud computing is particularly attractive in an era of reduced research funding, as it allows users to avoid the costs of maintaining hardware. However, cloud computing also presents challenges, such as data being stored across multiple clouds and the risk of data loss or damage. Researchers are experimenting with different methods to transfer large data sets quickly, such as using fasp, a software developed by Aspera. This technology allows for much faster data transfer than traditional internet protocols. Despite these challenges, the use of big data in biology is growing, with many researchers and institutions working to develop tools and platforms to handle the data. The Galaxy project, for example, allows scientists to analyze their data and share software tools and workflows for free. The Biomedical Information Science and Technology Initiative (BISTI) supports the development of new computational tools and the maintenance of existing ones. In the pharmaceutical industry, companies like Merrimack Pharmaceuticals are using big data to find new drug candidates and understand cancer biology. They store their data and conduct analysis on their own computing infrastructure to keep the data private and protected. The challenges of big data in biology are significant, but the opportunities are also vast. With the right tools and infrastructure, scientists can unlock new insights and discoveries that were previously impossible. The future of big data in biology is bright, but it requires continued investment in technology, training, and collaboration.Biologists and computer scientists are facing significant challenges with big data. As data sets grow, they need powerful computers to handle the massive amounts of information. High-throughput genomics has led to an explosion of data, with the European Bioinformatics Institute (EBI) storing 20 petabytes of data, including 2 petabytes from genomics. This is just a fraction of the data generated by CERN, but similar challenges exist in data storage, analysis, and sharing. Data mining in biology is complex due to the heterogeneity of biological data, which comes from various experiments and includes genetic sequences, protein interactions, and medical records. Scientists must store, analyze, and share large data sets, which is not simple. A single human genome is around 140 gigabytes, and comparing genomes requires more than a personal computer and online file-sharing applications. Cloud computing is becoming increasingly important in big data biology, allowing researchers to access computing power without needing their own hardware. The EBI is developing Embassy Cloud, a cloud-computing component for ELIXIR, which offers secure data-analysis environments. Cloud computing is particularly attractive in an era of reduced research funding, as it allows users to avoid the costs of maintaining hardware. However, cloud computing also presents challenges, such as data being stored across multiple clouds and the risk of data loss or damage. Researchers are experimenting with different methods to transfer large data sets quickly, such as using fasp, a software developed by Aspera. This technology allows for much faster data transfer than traditional internet protocols. Despite these challenges, the use of big data in biology is growing, with many researchers and institutions working to develop tools and platforms to handle the data. The Galaxy project, for example, allows scientists to analyze their data and share software tools and workflows for free. The Biomedical Information Science and Technology Initiative (BISTI) supports the development of new computational tools and the maintenance of existing ones. In the pharmaceutical industry, companies like Merrimack Pharmaceuticals are using big data to find new drug candidates and understand cancer biology. They store their data and conduct analysis on their own computing infrastructure to keep the data private and protected. The challenges of big data in biology are significant, but the opportunities are also vast. With the right tools and infrastructure, scientists can unlock new insights and discoveries that were previously impossible. The future of big data in biology is bright, but it requires continued investment in technology, training, and collaboration.